Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL19534765 | 0.97 | ALDH1A1 (0.55) | ALDH1A1TSHRNAPRTTDP1SLC22A12 | |
| Pivalate SCHEMBL1831791 | 0.86 | TSHR (0.50) | ALDH1A1TSHRNAPRTTDP1SLC22A12 | |
| Pivalate SCHEMBL28353815 | 0.84 | TSHR (0.47) | ALDH1A1TSHRNAPRTTDP1SLC22A12 | |
| Pyridine SCHEMBL19534764 | 0.83 | TSHR (0.41) | ALDH1A1TSHRNAPRTTDP1KMT2A | |
| Pyridine SCHEMBL11104571 | 0.83 | TSHR (0.60) | ALDH1A1TSHRNAPRTTDP1CYP1A2 | |
| Pyridine SCHEMBL10615224 | 0.80 | TSHR (0.56) | TSHRNAPRTTDP1 | |
| Methyl Alcohol SCHEMBL27642015 | 0.80 | — | — | |
| Pyridine SCHEMBL11731278 | 0.78 | TSHR (0.41) | ALDH1A1TSHRNAPRTTDP1SLC22A12 | |
| Pyridine SCHEMBL28101856 | 0.78 | TSHR (0.53) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL3467693 | 0.77 | NAPRT (0.60) | ALDH1A1TSHRNAPRTTDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352700-B2 | Compositions and methods for forming articles having silver metal | EASTMAN KODAK COMPANY (US) | 2022-06-07 | — | — | US | disclosed |
| EP-3496951-B1 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | EASTMAN KODAK CO (US) | 2021-06-23 | — | — | EP | disclosed |
| US-20190264331-A1 | COMPOSITIONS AND METHODS FOR FORMING ARTICLES HAVING SILVER METAL | BANK OF AMERICA, N.A., AS AGENT | 2019-08-29 | — | — | US | disclosed |
| US-10358725-B2 | Compositions and methods for forming articles having silver metal | EASTMAN KODAK COMPANY (US) | 2019-07-23 | — | — | US | disclosed |
| US-10356899-B2 | Articles having reducible silver ion complexes or silver metal | EASTMAN KODAK COMPANY (US) | 2019-07-16 | — | — | US | disclosed |
| EP-3496951-A1 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | Eastman Kodak Company (US) | 2019-06-19 | — | — | EP | disclosed |
| CN-109562628-A | Silver ion carboxylate N-heteroaromatic complex and use | 柯达公司 | 2019-04-02 | — | — | CN | disclosed |
| US-20190043635-A1 | PHOTOSENSITIVE REDUCIBLE SILVER ION-CONTAINING COMPOSITIONS | KODAK AVIATION LEASING LLC | 2019-02-07 | — | — | US | disclosed |
| US-10186342-B2 | Photosensitive reducible silver ion-containing compositions | EASTMAN KODAK COMPANY (US) | 2019-01-22 | — | — | US | disclosed |
| US-20180362547-A1 | COMPOSITIONS AND METHODS FOR FORMING ARTICLES HAVING SILVER METAL | BANK OF AMERICA, N.A., AS AGENT | 2018-12-20 | — | — | US | disclosed |
| US-10087331-B2 | Methods for forming and using silver metal | EASTMAN KODAK COMPANY (US) | 2018-10-02 | — | — | US | disclosed |
| US-20180049320-A1 | ARTICLES HAVING REDUCIBLE SILVER ION COMPLEXES OR SILVER METAL | BANK OF AMERICA, N.A., AS AGENT | 2018-02-15 | — | — | US | disclosed |
| US-20180044543-A1 | METHODS FOR FORMING AND USING SILVER METAL | BANK OF AMERICA, N.A., AS AGENT | 2018-02-15 | — | — | US | disclosed |
| US-20180047476-A1 | PHOTOSENSITIVE REDUCIBLE SILVER ION-CONTAINING COMPOSITIONS | BANK OF AMERICA, N.A., AS AGENT | 2018-02-15 | — | — | US | disclosed |
| WO-2018031235-A1 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | EASTMAN KODAK COMPANY (US) | 2018-02-15 | — | — | WO | disclosed |
| US-9809606-B1 | Silver ion carboxylate N-heteroaromatic complexes | EASTMAN KODAK COMPANY (US) | 2017-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180362547-A1 | COMPOSITIONS AND METHODS FOR FORMING ARTICLES HAVING SILVER METAL | HACL2, GLO1, CLTC | ALDH1A1 319/4885TSHR 4854/4885NAPRT 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.